Plasma Citrulline Level as a Biomarker for Cancer Therapy-Induced Small Bowel Mucosal Damage.

Acta Biochimica Polonica - Poland
doi 10.18388/abp.2014_1823
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Polskie Towarzystwo Biochemiczne (Polish Biochemical Society)

Related search

Carbonic Anhydrase I as a New Plasma Biomarker for Prostate Cancer

ISRN Oncology
2012English

Effectiveness of Polaprezinc for Low-Dose Aspirin-Induced Small-Bowel Mucosal Injuries as Evaluated by Capsule Endoscopy: A Pilot Randomized Controlled Study

BMC Gastroenterology
MedicineGastroenterology
2013English

Osteopontin -- A Promising Biomarker for Cancer Therapy

Journal of Cancer
Oncology
2017English

Identification of Plasma microRNA-21 as a Biomarker for Early Detection and Chemosensitivity of Non-Small Cell Lung Cancer

Chinese Journal of Cancer
2011English

Interleukin-36α as a Potential Biomarker for Renal Tubular Damage Induced by Dietary Phosphate Load

FEBS Open Bio
BiochemistryGeneticsMolecular Biology
2020English

Designing a Novel High-Throughput AlphaLISA Assay to Quantify Plasma NHERF1 as a Non-Small Cell Lung Cancer Biomarker

RSC Advances
ChemistryChemical Engineering
2015English

Filamin-A as a Marker and Target for DNA Damage Based Cancer Therapy

DNA Repair
BiochemistryCell BiologyMolecular Biology
2012English

Plasma Activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer

Scientific Reports
Multidisciplinary
2019English

Plasma Mesothelin as a Novel Diagnostic and Prognostic Biomarker in Colorectal Cancer

Journal of Cancer
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy